Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is AT&T a Buy?


U.S. telecommunications giant AT (NYSE: T) has lulled investors to sleep with its poor performance over most of the past decade. But the stock has enjoyed a face-ripping rally over the past year, surging nearly 60% at the time of this writing. Suddenly, at is a market-beating winner.

Some of the credit for that turnaround goes to the company, which has worked through a cumbersome debt load and failed acquisitions to return to its roots as a telecommunication-focused company. The company also rightsized its dividend a few years back, freeing up cash flow, and still offers a 4.1% yield today.

So, is the stock a buy? I dove into the numbers to determine whether AT can stay hot, and I've shared that below. AT's appeal ultimately depends on you. Here is what you need to know.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

?
0,00 %
Die Allergy Therapeutics PLC Aktie bleibt konstant, ohne jegliche Veränderung seit gestern.

Like: 0
T
Teilen

Kommentare